메뉴 건너뛰기




Volumn 46, Issue 3, 2011, Pages 153-163

Treatment of chronic graft-versus-host disease: Past, present and future

Author keywords

Chronic graft versus host disease; Phase II clinical trials; Review; Treatment

Indexed keywords


EID: 84859818703     PISSN: 17387949     EISSN: 20929129     Source Type: Journal    
DOI: 10.5045/kjh.2011.46.3.153     Document Type: Review
Times cited : (67)

References (106)
  • 1
    • 77953012692 scopus 로고    scopus 로고
    • Manifestations and treatment of acute graft-versus-host disease
    • Appelbaum FR, Forman SJ, Negrin RS, Blume KG, eds., 4th ed., Oxford, UK: Wiley-Blackwell
    • Cutler C, Antin JH. Manifestations and treatment of acute graft-versus-host disease. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, eds. Thomas' hematopoietic cell transplantation. 4th ed. Oxford, UK: Wiley-Blackwell, 2009:1287-303.
    • (2009) Thomas' hematopoietic cell transplantation , pp. 1287-1303
    • Cutler, C.1    Antin, J.H.2
  • 2
    • 84890663488 scopus 로고    scopus 로고
    • Chronic graft-versus-host disease: clinical manifestations and therapy
    • Appelbaum FR, Forman SJ, Negrin RS, Blume KG, eds., 4th ed., Oxford, UK: Wiley-Blackwell
    • Pavletic SZ, Vogelsang GB. Chronic graft-versus-host disease: clinical manifestations and therapy. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, eds. Thomas' hematopoietic cell transplantation. 4th ed. Oxford, UK: Wiley-Blackwell, 2009:1304-24.
    • (2009) Thomas' hematopoietic cell transplantation , pp. 1304-1324
    • Pavletic, S.Z.1    Vogelsang, G.B.2
  • 3
    • 0018973048 scopus 로고
    • Chronic graftversus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients
    • Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graftversus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-17.
    • (1980) Am J Med , vol.69 , pp. 204-217
    • Shulman, H.M.1    Sullivan, K.M.2    Weiden, P.L.3
  • 4
    • 28744444180 scopus 로고    scopus 로고
    • National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group Report
    • Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant 2005;11:945-56.
    • (2005) Biol Blood Marrow Transplant , vol.11 , pp. 945-956
    • Filipovich, A.H.1    Weisdorf, D.2    Pavletic, S.3
  • 5
    • 29844442863 scopus 로고    scopus 로고
    • Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology Working Group Report
    • Shulman HM, Kleiner D, Lee SJ, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant 2006;12:31-47.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 31-47
    • Shulman, H.M.1    Kleiner, D.2    Lee, S.J.3
  • 6
    • 31344452995 scopus 로고    scopus 로고
    • Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report
    • Schultz KR, Miklos DB, Fowler D, et al. Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report. Biol Blood Marrow Transplant 2006;12: 126-37.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 126-137
    • Schultz, K.R.1    Miklos, D.B.2    Fowler, D.3
  • 7
    • 33244456998 scopus 로고    scopus 로고
    • Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response Criteria Working Group Report
    • Pavletic SZ, Martin P, Lee SJ, et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response Criteria Working Group Report. Biol Blood Marrow Transplant 2006; 12:252-66.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 252-266
    • Pavletic, S.Z.1    Martin, P.2    Lee, S.J.3
  • 8
    • 33644905065 scopus 로고    scopus 로고
    • Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report
    • Couriel D, Carpenter PA, Cutler C, et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 2006;12:375-96.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 375-396
    • Couriel, D.1    Carpenter, P.A.2    Cutler, C.3
  • 9
    • 33745447476 scopus 로고    scopus 로고
    • National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: VI. Design of Clinical Trials Working Group Report
    • Martin PJ, Weisdorf D, Przepiorka D, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: VI. Design of Clinical Trials Working Group Report. Biol Blood Marrow Transplant 2006;12:491-505.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 491-505
    • Martin, P.J.1    Weisdorf, D.2    Przepiorka, D.3
  • 10
    • 9444243839 scopus 로고    scopus 로고
    • Duration of immunosuppressive treatment for chronic graft-versus-host disease
    • Stewart BL, Storer B, Storek J, et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 2004;104:3501-6.
    • (2004) Blood , vol.104 , pp. 3501-3506
    • Stewart, B.L.1    Storer, B.2    Storek, J.3
  • 11
    • 70149119758 scopus 로고    scopus 로고
    • Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD
    • Vigorito AC, Campregher PV, Storer BE, et al. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood 2009;114:702-8.
    • (2009) Blood , vol.114 , pp. 702-708
    • Vigorito, A.C.1    Campregher, P.V.2    Storer, B.E.3
  • 12
    • 79953109315 scopus 로고    scopus 로고
    • Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
    • Flowers ME, Inamoto Y, Carpenter PA, et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 2011;117:3214-9.
    • (2011) Blood , vol.117 , pp. 3214-3219
    • Flowers, M.E.1    Inamoto, Y.2    Carpenter, P.A.3
  • 13
    • 79959193801 scopus 로고    scopus 로고
    • Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research Analysis
    • Arora M, Klein JP, Weisdorf DJ, et al. Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research Analysis. Blood 2011;117:6714-20.
    • (2011) Blood , vol.117 , pp. 6714-6720
    • Arora, M.1    Klein, J.P.2    Weisdorf, D.J.3
  • 14
    • 69249193742 scopus 로고    scopus 로고
    • Standard graft-versushost disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
    • Finke J, Bethge WA, Schmoor C, et al. Standard graft-versushost disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol 2009;10:855-64.
    • (2009) Lancet Oncol , vol.10 , pp. 855-864
    • Finke, J.1    Bethge, W.A.2    Schmoor, C.3
  • 15
    • 78149464225 scopus 로고    scopus 로고
    • Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire
    • Mohty M, Labopin M, Balère ML, et al. Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire. Leukemia 2010;24:1867-74.
    • (2010) Leukemia , vol.24 , pp. 1867-1874
    • Mohty, M.1    Labopin, M.2    Balère, M.L.3
  • 17
    • 0019861205 scopus 로고
    • Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation
    • Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981;304:1529-33.
    • (1981) N Engl J Med , vol.304 , pp. 1529-1533
    • Weiden, P.L.1    Sullivan, K.M.2    Flournoy, N.3    Storb, R.4    Thomas, E.D.5
  • 18
    • 0024566585 scopus 로고
    • Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia
    • Sullivan KM, Weiden PL, Storb R, et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989;73: 1720-8.
    • (1989) Blood , vol.73 , pp. 1720-1728
    • Sullivan, K.M.1    Weiden, P.L.2    Storb, R.3
  • 19
    • 0025100777 scopus 로고
    • Graft-versus-leukemia reactions after bone marrow transplantation
    • Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990;75: 555-62.
    • (1990) Blood , vol.75 , pp. 555-562
    • Horowitz, M.M.1    Gale, R.P.2    Sondel, P.M.3
  • 20
    • 20144362213 scopus 로고    scopus 로고
    • Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning
    • Baron F, Maris MB, Sandmaier BM, et al. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Clin Oncol 2005;23:1993-2003.
    • (2005) Clin Oncol , vol.23 , pp. 1993-2003
    • Baron, F.1    Maris, M.B.2    Sandmaier, B.M.3
  • 21
    • 78149470443 scopus 로고    scopus 로고
    • The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versushost disease after reduced intensity conditioning before allogeneic stem cell transplantation
    • Thepot S, Zhou J, Perrot A, et al. The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versushost disease after reduced intensity conditioning before allogeneic stem cell transplantation. Leukemia 2010;24:1852-8.
    • (2010) Leukemia , vol.24 , pp. 1852-1858
    • Thepot, S.1    Zhou, J.2    Perrot, A.3
  • 22
    • 79960451644 scopus 로고    scopus 로고
    • Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation
    • Inamoto Y, Flowers ME, Lee SJ, et al. Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation. Blood 2011;118: 456-63.
    • (2011) Blood , vol.118 , pp. 456-463
    • Inamoto, Y.1    Flowers, M.E.2    Lee, S.J.3
  • 23
    • 0023713375 scopus 로고
    • Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation
    • Sullivan KM, Witherspoon RP, Storb R, et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 1988;72:546-54.
    • (1988) Blood , vol.72 , pp. 546-554
    • Sullivan, K.M.1    Witherspoon, R.P.2    Storb, R.3
  • 24
    • 0034554783 scopus 로고    scopus 로고
    • Thalidomide for treatment of patients with chronic graft-versus-host disease
    • Koc S, Leisenring W, Flowers ME, et al. Thalidomide for treatment of patients with chronic graft-versus-host disease. Blood 2000;96:3995-6.
    • (2000) Blood , vol.96 , pp. 3995-3996
    • Koc, S.1    Leisenring, W.2    Flowers, M.E.3
  • 25
    • 0034962328 scopus 로고    scopus 로고
    • Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease
    • Arora M, Wagner JE, Davies SM, et al. Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease. Biol Blood Marrow Transplant 2001; 7:265-73.
    • (2001) Biol Blood Marrow Transplant , vol.7 , pp. 265-273
    • Arora, M.1    Wagner, J.E.2    Davies, S.M.3
  • 26
    • 0036660429 scopus 로고    scopus 로고
    • Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone
    • Koc S, Leisenring W, Flowers ME, et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood 2002; 100:48-51.
    • (2002) Blood , vol.100 , pp. 48-51
    • Koc, S.1    Leisenring, W.2    Flowers, M.E.3
  • 27
    • 67149108714 scopus 로고    scopus 로고
    • Evaluation of mycophenolate mofetil for initial treatment of chronic graftversus-host disease
    • Martin PJ, Storer BE, Rowley SD, et al. Evaluation of mycophenolate mofetil for initial treatment of chronic graftversus-host disease. Blood 2009;113:5074-82.
    • (2009) Blood , vol.113 , pp. 5074-5082
    • Martin, P.J.1    Storer, B.E.2    Rowley, S.D.3
  • 28
    • 84855421339 scopus 로고    scopus 로고
    • Randomized trial of hydroxychloroquine for newly diagnosed chronic graftversus-host disease in children: a children's oncology group study
    • [Epub ahead of print]
    • Gilman AL, Schultz KR, Goldman FD, et al. Randomized trial of hydroxychloroquine for newly diagnosed chronic graftversus-host disease in children: a children's oncology group study. Biol Blood Marrow Transplant 2011 [Epub ahead of print].
    • (2011) Biol Blood Marrow Transplant
    • Gilman, A.L.1    Schultz, K.R.2    Goldman, F.D.3
  • 29
  • 30
    • 80054743948 scopus 로고    scopus 로고
    • Front line treatment of chronic GVHD
    • Vogelsang GB, Pavletic SZ, eds. New York, NY: Cambridge University Press
    • Martin P, Gilman AL. Front line treatment of chronic GVHD. In: Vogelsang GB, Pavletic SZ, eds. Chronic graft versus host disease: interdisciplinary management. New York, NY: Cambridge University Press, 2009:124-33.
    • (2009) Chronic graft versus host disease: interdisciplinary management , pp. 124-133
    • Martin, P.1    Gilman, A.L.2
  • 31
    • 0037100280 scopus 로고    scopus 로고
    • Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial
    • Flowers ME, Parker PM, Johnston LJ, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 2002;100:415-9.
    • (2002) Blood , vol.100 , pp. 415-419
    • Flowers, M.E.1    Parker, P.M.2    Johnston, L.J.3
  • 32
    • 69849102119 scopus 로고    scopus 로고
    • Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective
    • Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009;15:1143-238.
    • (2009) Biol Blood Marrow Transplant , vol.15 , pp. 1143-1238
    • Tomblyn, M.1    Chiller, T.2    Einsele, H.3
  • 33
    • 0037438514 scopus 로고    scopus 로고
    • Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity
    • Boeckh M, Leisenring W, Riddell SR, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 2003;101:407-14.
    • (2003) Blood , vol.101 , pp. 407-414
    • Boeckh, M.1    Leisenring, W.2    Riddell, S.R.3
  • 34
    • 0000892990 scopus 로고
    • Studies on an intermittent corticosteroid dosage regimen
    • Harter JG, Reddy WJ, Thorn GW. Studies on an intermittent corticosteroid dosage regimen. N Engl J Med 1963;269:591-6.
    • (1963) N Engl J Med , vol.269 , pp. 591-596
    • Harter, J.G.1    Reddy, W.J.2    Thorn, G.W.3
  • 35
    • 77957676790 scopus 로고    scopus 로고
    • Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD
    • Wolff D, Gerbitz A, Ayuk F, et al. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant 2010;16:1611-28.
    • (2010) Biol Blood Marrow Transplant , vol.16 , pp. 1611-1628
    • Wolff, D.1    Gerbitz, A.2    Ayuk, F.3
  • 36
    • 79955632748 scopus 로고    scopus 로고
    • Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease
    • Wolff D, Schleuning M, von Harsdorf S, et al. Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2011;17:1-17.
    • (2011) Biol Blood Marrow Transplant , vol.17 , pp. 1-17
    • Wolff, D.1    Schleuning, M.2    von Harsdorf, S.3
  • 37
    • 0036169694 scopus 로고    scopus 로고
    • A survey of diagnosis, management, and grading of chronic GVHD
    • Lee SJ, Vogelsang G, Gilman A, et al. A survey of diagnosis, management, and grading of chronic GVHD. Biol Blood Marrow Transplant 2002;8:32-9.
    • (2002) Biol Blood Marrow Transplant , vol.8 , pp. 32-39
    • Lee, S.J.1    Vogelsang, G.2    Gilman, A.3
  • 38
    • 84859819233 scopus 로고    scopus 로고
    • ASBMT eNEWS Survey. Arlington Heights, IL: American Society for Blood and Marrow Transplantation, (Accessed June 15, 2011, at)
    • ASBMT eNEWS Survey. Arlington Heights, IL: American Society for Blood and Marrow Transplantation, 2008. (Accessed June 15, 2011, at http://www.news-source.org/ASBMT/Archive/2008/asbmtonline04-01-08.htm.)
    • (2008)
  • 39
    • 0032832979 scopus 로고    scopus 로고
    • Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
    • Mookerjee B, Altomonte V, Vogelsang G. Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus. Bone Marrow Transplant 1999;24: 517-20.
    • (1999) Bone Marrow Transplant , vol.24 , pp. 517-520
    • Mookerjee, B.1    Altomonte, V.2    Vogelsang, G.3
  • 40
    • 0034102824 scopus 로고    scopus 로고
    • Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation
    • Busca A, Saroglia EM, Lanino E, et al. Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation. Bone Marrow Transplant 2000;25:1067-71.
    • (2000) Bone Marrow Transplant , vol.25 , pp. 1067-1071
    • Busca, A.1    Saroglia, E.M.2    Lanino, E.3
  • 41
    • 0036740742 scopus 로고    scopus 로고
    • Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients
    • Baudard M, Vincent A, Moreau P, Kergueris MF, Harousseau JL, Milpied N. Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients. Marrow Transplant 2002;30: 287-95.
    • (2002) Marrow Transplant , vol.30 , pp. 287-295
    • Baudard, M.1    Vincent, A.2    Moreau, P.3    Kergueris, M.F.4    Harousseau, J.L.5    Milpied, N.6
  • 42
    • 0038376700 scopus 로고    scopus 로고
    • Response to mycophenolate mofetil therapy in refractory chronic graftversus-host disease
    • Busca A, Locatelli F, Marmont F, Audisio E, Falda M. Response to mycophenolate mofetil therapy in refractory chronic graftversus-host disease. Haematologica 2003;88:837-9.
    • (2003) Haematologica , vol.88 , pp. 837-839
    • Busca, A.1    Locatelli, F.2    Marmont, F.3    Audisio, E.4    Falda, M.5
  • 43
    • 3042612312 scopus 로고    scopus 로고
    • Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant
    • Kim JG, Sohn SK, Kim DH, et al. Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant. Eur J Haematol 2004;73:56-61.
    • (2004) Eur J Haematol , vol.73 , pp. 56-61
    • Kim, J.G.1    Sohn, S.K.2    Kim, D.H.3
  • 44
    • 27644507409 scopus 로고    scopus 로고
    • Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease
    • Krejci M, Doubek M, Buchler T, Brychtova Y, Vorlicek J, Mayer J. Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease. Ann Hematol 2005; 84:681-5.
    • (2005) Ann Hematol , vol.84 , pp. 681-685
    • Krejci, M.1    Doubek, M.2    Buchler, T.3    Brychtova, Y.4    Vorlicek, J.5    Mayer, J.6
  • 45
    • 20144388150 scopus 로고    scopus 로고
    • Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease
    • Lopez F, Parker P, Nademanee A, et al. Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2005;11:307-13.
    • (2005) Biol Blood Marrow Transplant , vol.11 , pp. 307-313
    • Lopez, F.1    Parker, P.2    Nademanee, A.3
  • 46
    • 31644451399 scopus 로고    scopus 로고
    • Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease
    • Takami A, Mochizuki K, Okumura H, et al. Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease. Int J Hematol 2006;83:80-5.
    • (2006) Int J Hematol , vol.83 , pp. 80-85
    • Takami, A.1    Mochizuki, K.2    Okumura, H.3
  • 47
    • 77950917873 scopus 로고    scopus 로고
    • A high risk of lifethreatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
    • Onishi C, Ohashi K, Sawada T, et al. A high risk of lifethreatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease. Int J Hematol 2010;91:464-70.
    • (2010) Int J Hematol , vol.91 , pp. 464-470
    • Onishi, C.1    Ohashi, K.2    Sawada, T.3
  • 48
    • 75049084631 scopus 로고    scopus 로고
    • Therapy with mycophenolate mofetil for refractory acute and chronic GVHD
    • Furlong T, Martin P, Flowers ME, et al. Therapy with mycophenolate mofetil for refractory acute and chronic GVHD. Bone Marrow Transplant 2009;44:739-48.
    • (2009) Bone Marrow Transplant , vol.44 , pp. 739-748
    • Furlong, T.1    Martin, P.2    Flowers, M.E.3
  • 49
    • 0026514939 scopus 로고
    • Thalidomide for the treatment of chronic graft-versus-host disease
    • Vogelsang GB, Farmer ER, Hess AD, et al. Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med 1992;326:1055-8.
    • (1992) N Engl J Med , vol.326 , pp. 1055-1058
    • Vogelsang, G.B.1    Farmer, E.R.2    Hess, A.D.3
  • 50
    • 0028840974 scopus 로고
    • Thalidomide as salvage therapy for chronic graft-versus-host disease
    • Parker PM, Chao N, Nademanee A, et al. Thalidomide as salvage therapy for chronic graft-versus-host disease. Blood 1995;86: 3604-9.
    • (1995) Blood , vol.86 , pp. 3604-3609
    • Parker, P.M.1    Chao, N.2    Nademanee, A.3
  • 51
    • 0031884832 scopus 로고    scopus 로고
    • The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children
    • Rovelli A, Arrigo C, Nesi F, et al. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children. Bone Marrow Transplant 1998;21:577-81.
    • (1998) Bone Marrow Transplant , vol.21 , pp. 577-581
    • Rovelli, A.1    Arrigo, C.2    Nesi, F.3
  • 52
    • 0033754011 scopus 로고    scopus 로고
    • Response to thalidomide therapy in refractory chronic graft-versus-host disease
    • Browne PV, Weisdorf DJ, DeFor T, et al. Response to thalidomide therapy in refractory chronic graft-versus-host disease. Bone Marrow Transplant 2000;26:865-9.
    • (2000) Bone Marrow Transplant , vol.26 , pp. 865-869
    • Browne, P.V.1    Weisdorf, D.J.2    DeFor, T.3
  • 53
    • 0034907091 scopus 로고    scopus 로고
    • The use of thalidomide in chronic refractory graft versus host disease
    • van de Poel MH, Pasman PC, Schouten HC. The use of thalidomide in chronic refractory graft versus host disease. Neth J Med 2001;59:45-9.
    • (2001) Neth J Med , vol.59 , pp. 45-49
    • van de Poel, M.H.1    Pasman, P.C.2    Schouten, H.C.3
  • 54
    • 10744230404 scopus 로고    scopus 로고
    • Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease
    • Kulkarni S, Powles R, Sirohi B, et al. Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease. Bone Marrow Transplant 2003;32:165-70.
    • (2003) Bone Marrow Transplant , vol.32 , pp. 165-170
    • Kulkarni, S.1    Powles, R.2    Sirohi, B.3
  • 55
    • 56549114909 scopus 로고    scopus 로고
    • Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease
    • Flowers ME, Storer B, Carpenter P, et al. Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease. Biol Blood Marrow Transplant 2008; 14:1380-4.
    • (2008) Biol Blood Marrow Transplant , vol.14 , pp. 1380-1384
    • Flowers, M.E.1    Storer, B.2    Carpenter, P.3
  • 56
    • 3042651139 scopus 로고    scopus 로고
    • Grading quality of evidence and strength of recommendations
    • Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490.
    • (2004) BMJ , vol.328 , pp. 1490
    • Atkins, D.1    Best, D.2    Briss, P.A.3
  • 57
    • 79955984501 scopus 로고    scopus 로고
    • The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
    • Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011;117:4190-207.
    • (2011) Blood , vol.117 , pp. 4190-4207
    • Neunert, C.1    Lim, W.2    Crowther, M.3    Cohen, A.4    Solberg Jr., L.5    Crowther, M.A.6
  • 58
    • 33745964855 scopus 로고    scopus 로고
    • Rituximab for steroidrefractory chronic graft-versus-host disease
    • Cutler C, Miklos D, Kim HT, et al. Rituximab for steroidrefractory chronic graft-versus-host disease. Blood 2006;108: 756-62.
    • (2006) Blood , vol.108 , pp. 756-762
    • Cutler, C.1    Miklos, D.2    Kim, H.T.3
  • 59
  • 60
    • 56049118902 scopus 로고    scopus 로고
    • Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab
    • von Bonin M, Oelschlägel U, Radke J, et al. Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab. Transplantation 2008;86:875-9.
    • (2008) Transplantation , vol.86 , pp. 875-879
    • von Bonin, M.1    Oelschlägel, U.2    Radke, J.3
  • 61
    • 78149243861 scopus 로고    scopus 로고
    • Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study
    • Kim SJ, Lee JW, Jung CW, et al. Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study. Haematologica 2010;95:1935-42.
    • (2010) Haematologica , vol.95 , pp. 1935-1942
    • Kim, S.J.1    Lee, J.W.2    Jung, C.W.3
  • 62
    • 70149123508 scopus 로고    scopus 로고
    • Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease
    • Magro L, Mohty M, Catteau B, et al. Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease. Blood 2009;114:719-22.
    • (2009) Blood , vol.114 , pp. 719-722
    • Magro, L.1    Mohty, M.2    Catteau, B.3
  • 63
    • 70149102515 scopus 로고    scopus 로고
    • Imatinib for refractory chronic graft-versus-host disease with fibrotic features
    • Olivieri A, Locatelli F, Zecca M, et al. Imatinib for refractory chronic graft-versus-host disease with fibrotic features. Blood 2009;114:709-18.
    • (2009) Blood , vol.114 , pp. 709-718
    • Olivieri, A.1    Locatelli, F.2    Zecca, M.3
  • 64
    • 34948840917 scopus 로고    scopus 로고
    • Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease
    • Jacobsohn DA, Chen AR, Zahurak M, et al. Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease. J Clin Oncol 2007;25:4255-61.
    • (2007) J Clin Oncol , vol.25 , pp. 4255-4261
    • Jacobsohn, D.A.1    Chen, A.R.2    Zahurak, M.3
  • 65
    • 73349089953 scopus 로고    scopus 로고
    • Evaluation of pentostatin in corticosteroid-refractory chronic graft-versushost disease in children: a Pediatric Blood and Marrow Transplant Consortium Study
    • Jacobsohn DA, Gilman AL, Rademaker A, et al. Evaluation of pentostatin in corticosteroid-refractory chronic graft-versushost disease in children: a Pediatric Blood and Marrow Transplant Consortium Study. Blood 2009;114:4354-60.
    • (2009) Blood , vol.114 , pp. 4354-4360
    • Jacobsohn, D.A.1    Gilman, A.L.2    Rademaker, A.3
  • 66
    • 78651251952 scopus 로고    scopus 로고
    • Pentostatin as rescue therapy for glucocorticoid-refractory acute and chronic graft-versus-host disease
    • Pidala J, Kim J, Roman-Diaz J, et al. Pentostatin as rescue therapy for glucocorticoid-refractory acute and chronic graft-versus-host disease. Ann Transplant 2010;15:21-9.
    • (2010) Ann Transplant , vol.15 , pp. 21-29
    • Pidala, J.1    Kim, J.2    Roman-Diaz, J.3
  • 67
    • 78650208987 scopus 로고    scopus 로고
    • Mesenchymal stem cell as salvage treatment for refractory chronic GVHD
    • Weng JY, Du X, Geng SX, et al. Mesenchymal stem cell as salvage treatment for refractory chronic GVHD. Bone Marrow Transplant 2010;45:1732-40.
    • (2010) Bone Marrow Transplant , vol.45 , pp. 1732-1740
    • Weng, J.Y.1    Du, X.2    Geng, S.X.3
  • 68
    • 0032212219 scopus 로고    scopus 로고
    • Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease
    • Greinix HT, Volc-Platzer B, Rabitsch W, et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998;92: 3098-104.
    • (1998) Blood , vol.92 , pp. 3098-3104
    • Greinix, H.T.1    Volc-Platzer, B.2    Rabitsch, W.3
  • 69
    • 0031615427 scopus 로고    scopus 로고
    • Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs-host disease
    • Smith EP, Sniecinski I, Dagis AC, et al. Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease. Biol Blood Marrow Transplant 1998;4:27-37.
    • (1998) Biol Blood Marrow Transplant , vol.4 , pp. 27-37
    • Smith, E.P.1    Sniecinski, I.2    Dagis, A.C.3
  • 70
    • 0032957559 scopus 로고    scopus 로고
    • Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD)
    • Child FJ, Ratnavel R, Watkins P, et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 1999;23:881-7.
    • (1999) Bone Marrow Transplant , vol.23 , pp. 881-887
    • Child, F.J.1    Ratnavel, R.2    Watkins, P.3
  • 71
    • 0035469829 scopus 로고    scopus 로고
    • Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease
    • Alcindor T, Gorgun G, Miller KB, et al. Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease. Blood 2001;98:1622-5.
    • (2001) Blood , vol.98 , pp. 1622-1625
    • Alcindor, T.1    Gorgun, G.2    Miller, K.B.3
  • 72
    • 0034782157 scopus 로고    scopus 로고
    • Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood
    • Salvaneschi L, Perotti C, Zecca M, et al. Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion 2001;41:1299-305.
    • (2001) Transfusion , vol.41 , pp. 1299-1305
    • Salvaneschi, L.1    Perotti, C.2    Zecca, M.3
  • 73
    • 0242417628 scopus 로고    scopus 로고
    • Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results
    • Apisarnthanarax N, Donato M, Körbling M, et al. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant 2003;31:459-65.
    • (2003) Bone Marrow Transplant , vol.31 , pp. 459-465
    • Apisarnthanarax, N.1    Donato, M.2    Körbling, M.3
  • 74
    • 0038345300 scopus 로고    scopus 로고
    • Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation
    • Messina C, Locatelli F, Lanino E, et al. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. Br J Haematol 2003;122:118-27.
    • (2003) Br J Haematol , vol.122 , pp. 118-127
    • Messina, C.1    Locatelli, F.2    Lanino, E.3
  • 75
    • 0043240283 scopus 로고    scopus 로고
    • Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response
    • Seaton ED, Szydlo RM, Kanfer E, Apperley JF, Russell-Jones R. Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood 2003;102:1217-23.
    • (2003) Blood , vol.102 , pp. 1217-1223
    • Seaton, E.D.1    Szydlo, R.M.2    Kanfer, E.3    Apperley, J.F.4    Russell-Jones, R.5
  • 76
    • 21244484653 scopus 로고    scopus 로고
    • Prospective study of extracorporeal photopheresis in steroid-refractory or steroidresistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors
    • Foss FM, DiVenuti GM, Chin K, et al. Prospective study of extracorporeal photopheresis in steroid-refractory or steroidresistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant 2005;35:1187-93.
    • (2005) Bone Marrow Transplant , vol.35 , pp. 1187-1193
    • Foss, F.M.1    DiVenuti, G.M.2    Chin, K.3
  • 77
    • 24944534610 scopus 로고    scopus 로고
    • Role of extracorporeal photochemotherapy in patients with refractory chronic graftversus-host disease
    • Rubegni P, Cuccia A, Sbano P, et al. Role of extracorporeal photochemotherapy in patients with refractory chronic graftversus-host disease. Br J Haematol 2005;130:271-5.
    • (2005) Br J Haematol , vol.130 , pp. 271-275
    • Rubegni, P.1    Cuccia, A.2    Sbano, P.3
  • 78
    • 33745795381 scopus 로고    scopus 로고
    • Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy
    • Bisaccia E, Palangio M, Gonzalez J, et al. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy. J Clin Apher 2006;21:181-7.
    • (2006) J Clin Apher , vol.21 , pp. 181-187
    • Bisaccia, E.1    Palangio, M.2    Gonzalez, J.3
  • 79
    • 33645733724 scopus 로고    scopus 로고
    • Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD
    • Couriel DR, Hosing C, Saliba R, et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006;107:3074-80.
    • (2006) Blood , vol.107 , pp. 3074-3080
    • Couriel, D.R.1    Hosing, C.2    Saliba, R.3
  • 80
    • 35148896347 scopus 로고    scopus 로고
    • Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report
    • Berger M, Pessolano R, Albiani R, et al. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report. J Pediatr Hematol Oncol 2007;29:678-87.
    • (2007) J Pediatr Hematol Oncol , vol.29 , pp. 678-687
    • Berger, M.1    Pessolano, R.2    Albiani, R.3
  • 81
    • 33947422891 scopus 로고    scopus 로고
    • Extracorporeal photochemotherapy for the treatment of chronic graft-versushost disease: trend for a possible cell dose-related effect?
    • Perseghin P, Galimberti S, Balduzzi A, et al. Extracorporeal photochemotherapy for the treatment of chronic graft-versushost disease: trend for a possible cell dose-related effect? Ther Apher Dial 2007;11:85-93.
    • (2007) Ther Apher Dial , vol.11 , pp. 85-93
    • Perseghin, P.1    Galimberti, S.2    Balduzzi, A.3
  • 82
    • 53449088758 scopus 로고    scopus 로고
    • A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease
    • Flowers ME, Apperley JF, van Besien K, et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 2008;112:2667-74.
    • (2008) Blood , vol.112 , pp. 2667-2674
    • Flowers, M.E.1    Apperley, J.F.2    van Besien, K.3
  • 83
    • 69749096116 scopus 로고    scopus 로고
    • Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP)
    • Jagasia MH, Savani BN, Stricklin G, et al. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biol Blood Marrow Transplant 2009;15:1288-95.
    • (2009) Biol Blood Marrow Transplant , vol.15 , pp. 1288-1295
    • Jagasia, M.H.1    Savani, B.N.2    Stricklin, G.3
  • 84
    • 77953106593 scopus 로고    scopus 로고
    • Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients
    • Perotti C, Del Fante C, Tinelli C, et al. Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients. Transfusion 2010;50:1359-69.
    • (2010) Transfusion , vol.50 , pp. 1359-1369
    • Perotti, C.1    Del Fante, C.2    Tinelli, C.3
  • 85
    • 0026349522 scopus 로고
    • FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation
    • Tzakis AG, Abu-Elmagd K, Fung JJ, et al. FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation. Transplant Proc 1991;23:3225-7.
    • (1991) Transplant Proc , vol.23 , pp. 3225-3227
    • Tzakis, A.G.1    Abu-Elmagd, K.2    Fung, J.J.3
  • 86
    • 0029062592 scopus 로고
    • FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants
    • Kanamaru A, Takemoto Y, Kakishita E, et al. FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group. Bone Marrow Transplant 1995;15:885-9.
    • (1995) Japanese FK506 BMT Study Group. Bone Marrow Transplant , vol.15 , pp. 885-889
    • Kanamaru, A.1    Takemoto, Y.2    Kakishita, E.3
  • 87
    • 0033657112 scopus 로고    scopus 로고
    • Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease
    • Carnevale-Schianca F, Martin P, Sullivan K, et al. Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease. Biol Blood Marrow Transplant 2000; 6:613-20.
    • (2000) Biol Blood Marrow Transplant , vol.6 , pp. 613-620
    • Carnevale-Schianca, F.1    Martin, P.2    Sullivan, K.3
  • 88
  • 89
    • 24944570255 scopus 로고    scopus 로고
    • Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease
    • Couriel DR, Saliba R, Escalón MP, et al. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol 2005;130:409-17.
    • (2005) Br J Haematol , vol.130 , pp. 409-417
    • Couriel, D.R.1    Saliba, R.2    Escalón, M.P.3
  • 90
    • 11244289077 scopus 로고    scopus 로고
    • Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease
    • Johnston LJ, Brown J, Shizuru JA, et al. Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2005;11:47-55.
    • (2005) Biol Blood Marrow Transplant , vol.11 , pp. 47-55
    • Johnston, L.J.1    Brown, J.2    Shizuru, J.A.3
  • 91
    • 34248652434 scopus 로고    scopus 로고
    • Sirolimus as part of immunosuppressive therapy for refractory chronic graftversus-host disease
    • Jurado M, Vallejo C, Pérez-Simón JA, et al. Sirolimus as part of immunosuppressive therapy for refractory chronic graftversus-host disease. Biol Blood Marrow Transplant 2007;13: 701-6.
    • (2007) Biol Blood Marrow Transplant , vol.13 , pp. 701-706
    • Jurado, M.1    Vallejo, C.2    Pérez-Simón, J.A.3
  • 93
    • 0037181125 scopus 로고    scopus 로고
    • Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease
    • Chiang KY, Abhyankar S, Bridges K, Godder K, Henslee-Downey JP. Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease. Transplantation 2002;73:665-7.
    • (2002) Transplantation , vol.73 , pp. 665-667
    • Chiang, K.Y.1    Abhyankar, S.2    Bridges, K.3    Godder, K.4    Henslee-Downey, J.P.5
  • 94
    • 23944454392 scopus 로고    scopus 로고
    • Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease
    • Giaccone L, Martin P, Carpenter P, et al. Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease. Bone Marrow Transplant 2005;36: 337-41.
    • (2005) Bone Marrow Transplant , vol.36 , pp. 337-341
    • Giaccone, L.1    Martin, P.2    Carpenter, P.3
  • 95
    • 23944519423 scopus 로고    scopus 로고
    • Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    • Huang XJ, Jiang Q, Chen H, et al. Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2005;36:343-8.
    • (2005) Bone Marrow Transplant , vol.36 , pp. 343-348
    • Huang, X.J.1    Jiang, Q.2    Chen, H.3
  • 97
    • 25444491999 scopus 로고    scopus 로고
    • Low-dose thoracoabdominal irradiation for the treatment of refractory chronic graft-versus-host disease
    • Robin M, Guardiola P, Girinsky T, et al. Low-dose thoracoabdominal irradiation for the treatment of refractory chronic graft-versus-host disease. Transplantation 2005;80:634-42.
    • (2005) Transplantation , vol.80 , pp. 634-642
    • Robin, M.1    Guardiola, P.2    Girinsky, T.3
  • 98
    • 0034781710 scopus 로고    scopus 로고
    • A high-dose pulse steroid regimen for controlling active chronic graftversus-host disease
    • Akpek G, Lee SM, Anders V, Vogelsang GB. A high-dose pulse steroid regimen for controlling active chronic graftversus-host disease. Biol Blood Marrow Transplant 2001;7:495-502.
    • (2001) Biol Blood Marrow Transplant , vol.7 , pp. 495-502
    • Akpek, G.1    Lee, S.M.2    Anders, V.3    Vogelsang, G.B.4
  • 99
    • 0033642532 scopus 로고    scopus 로고
    • Hydroxychloroquine for the treatment of chronic graft-versus-host disease
    • Gilman AL, Chan KW, Mogul A, et al. Hydroxychloroquine for the treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2000;6:327-34.
    • (2000) Biol Blood Marrow Transplant , vol.6 , pp. 327-334
    • Gilman, A.L.1    Chan, K.W.2    Mogul, A.3
  • 100
  • 101
    • 0032933608 scopus 로고    scopus 로고
    • Etretinate therapy for refractory sclerodermatous chronic graft-versushost disease
    • Marcellus DC, Altomonte VL, Farmer ER, et al. Etretinate therapy for refractory sclerodermatous chronic graft-versushost disease. Blood 1999;93:66-70.
    • (1999) Blood , vol.93 , pp. 66-70
    • Marcellus, D.C.1    Altomonte, V.L.2    Farmer, E.R.3
  • 102
    • 58249097301 scopus 로고    scopus 로고
    • Feasibility of NIH consensus criteria for chronic graft-versus-host disease
    • Cho BS, Min CK, Eom KS, et al. Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia 2009; 23:78-84.
    • (2009) Leukemia , vol.23 , pp. 78-84
    • Cho, B.S.1    Min, C.K.2    Eom, K.S.3
  • 103
    • 80054090049 scopus 로고    scopus 로고
    • Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria
    • [Epub ahead of print]
    • Arai S, Jagasia M, Storer B, et al. Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. Blood 2011 [Epub ahead of print].
    • (2011) Blood
    • Arai, S.1    Jagasia, M.2    Storer, B.3
  • 104
    • 79956201323 scopus 로고    scopus 로고
    • Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease
    • Martin PJ, Storer BE, Carpenter PA, et al. Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2011;17:124-32.
    • (2011) Biol Blood Marrow Transplant , vol.17 , pp. 124-132
    • Martin, P.J.1    Storer, B.E.2    Carpenter, P.A.3
  • 105
    • 67650302854 scopus 로고    scopus 로고
    • Phase II trials in journal of clinical oncology
    • Cannistra SA. Phase II trials in journal of clinical oncology. J Clin Oncol 2009;27:3073-6.
    • (2009) J Clin Oncol , vol.27 , pp. 3073-3076
    • Cannistra, S.A.1
  • 106
    • 84859840895 scopus 로고    scopus 로고
    • Alexandria, VA: The American Society of Clinical Oncology (Accessed July 20, at)
    • Journal of Clinical Oncology Information for Contributors. Alexandria, VA: The American Society of Clinical Oncology (Accessed July 20, 2011, at http://jco.ascopubs.org/site/ifc/ categories.xhtml.)
    • (2011) Journal of Clinical Oncology Information for Contributors


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.